Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-04-17 @ 8:24 AM
Study NCT ID:
NCT01597050
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2012-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Sponsor:
Rigel Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-932333-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None